These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

485 related items for PubMed ID: 19250769

  • 1. Local control and survival following concomitant chemoradiotherapy in inoperable stage I non-small-cell lung cancer.
    Campeau MP, Herschtal A, Wheeler G, Mac Manus M, Wirth A, Michael M, Hogg A, Drummond E, Ball D.
    Int J Radiat Oncol Biol Phys; 2009 Aug 01; 74(5):1371-5. PubMed ID: 19250769
    [Abstract] [Full Text] [Related]

  • 2. Phase II study of radiotherapy with three-dimensional conformal boost concurrent with paclitaxel and cisplatin for Stage IIIB non-small-cell lung cancer.
    Kim YS, Yoon SM, Choi EK, Yi BY, Kim JH, Ahn SD, Lee SW, Shin SS, Lee JS, Suh C, Kim SW, Kim DS, Kim WS, Park HJ, Park CI.
    Int J Radiat Oncol Biol Phys; 2005 May 01; 62(1):76-81. PubMed ID: 15850905
    [Abstract] [Full Text] [Related]

  • 3. [Survival status of stage IV non-small cell lung cancer patients after radiotherapy--a report of 287 cases].
    Cai Y, Wang WL, Xu B, Zhu GY, Zhang SW.
    Ai Zheng; 2006 Nov 01; 25(11):1419-22. PubMed ID: 17094913
    [Abstract] [Full Text] [Related]

  • 4. A Phase II study of synchronous three-dimensional conformal boost to the gross tumor volume for patients with unresectable Stage III non-small-cell lung cancer: results of Korean Radiation Oncology Group 0301 study.
    Cho KH, Ahn SJ, Pyo HR, Kim KS, Kim YC, Moon SH, Han JY, Kim HT, Koom WS, Lee JS.
    Int J Radiat Oncol Biol Phys; 2009 Aug 01; 74(5):1397-404. PubMed ID: 19117690
    [Abstract] [Full Text] [Related]

  • 5. Results of multifield conformal radiation therapy of nonsmall-cell lung carcinoma using multileaf collimation beams.
    Bahri S, Flickinger JC, Kalend AM, Deutsch M, Belani CP, Sciurba FC, Luketich JD, Greenberger JS.
    Radiat Oncol Investig; 1999 Aug 01; 7(5):297-308. PubMed ID: 10580899
    [Abstract] [Full Text] [Related]

  • 6. [Initial outcome of induction chemotherapy with weekly paclitaxel followed by three-dimensional conformal radiotherapy and concurrent weekly paclitaxel for stage III non-small cell lung cancer].
    Wang WH, Bao Y, Chen M, Zhang L, Li KX, Xu GC, Deng XW, Lu TX, Cui NJ.
    Ai Zheng; 2006 Oct 01; 25(10):1279-83. PubMed ID: 17059776
    [Abstract] [Full Text] [Related]

  • 7. Feasibility of high-dose three-dimensional radiation therapy in the treatment of localised non-small-cell lung cancer.
    Bellière A, Girard N, Chapet O, Khodri M, Kubas A, Souquet PJ, Mornex F.
    Cancer Radiother; 2009 Jul 01; 13(4):298-304. PubMed ID: 19525134
    [Abstract] [Full Text] [Related]

  • 8. Phase II trial of combined modality therapy with concurrent topotecan plus radiotherapy followed by consolidation chemotherapy for unresectable stage III and selected stage IV non-small-lung cancer.
    Seung SK, Ross HJ.
    Int J Radiat Oncol Biol Phys; 2009 Mar 01; 73(3):802-9. PubMed ID: 18762390
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Multivariate analysis of survival, local control, and time to distant metastases in patients with unresectable non-small-cell lung carcinoma treated with 3-dimensional conformal radiation therapy with or without concurrent chemotherapy.
    Wolski MJ, Bhatnagar A, Flickinger JC, Belani CP, Ramalingam S, Greenberger JS.
    Clin Lung Cancer; 2005 Sep 01; 7(2):100-6. PubMed ID: 16179096
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Patterns of disease failure after trimodality therapy of nonsmall cell lung carcinoma pathologic stage IIIA (N2). Analysis of Cancer and Leukemia Group B Protocol 8935.
    Kumar P, Herndon J, Langer M, Kohman LJ, Elias AD, Kass FC, Eaton WL, Seagren SL, Green MR, Sugarbaker DJ.
    Cancer; 1996 Jun 01; 77(11):2393-9. PubMed ID: 8635112
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Phase II study of concurrent chemoradiotherapy for inoperable (bulky) stage III (A/B) non-small cell lung cancer (NSCLC): a preliminary report.
    Ratanatharathorn V, Lorvidhaya V, Kraipiboon P, Sirachainan E, Maoleekoonpairoj S, Phromratanapongse P, Cheirsilpa A, Tangkaratt S, Srimuninnimit V, Pattaranutaporn P, Lertsanguansinchai P.
    J Med Assoc Thai; 2000 Jan 01; 83(1):85-92. PubMed ID: 10710874
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.